Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $3,121 | $3,703 | $3,155 | $2,676 | $2,820 |
| Gross Profit | $1,786 | $2,207 | $1,867 | $1,537 | $1,649 |
| Operating Income | $928 | $1,201 | $832 | $501 | $594 |
| Net Income | $784 | $1,015 | $716 | $449 | $542 |
Over the five-year period, TERADYNE, INC. experienced notable fluctuations in its key income statement metrics. In 2020, the company generated revenue of approximately 3121 million USD, which grew by about 19% to 3703 million USD in 2021—a year that also saw increases in gross profit (from roughly 1786 million USD to 2207 million USD) and operating income (928 to 1201 million USD). However, the upward momentum was not sustained. Revenue declined by roughly 15% in 2022 to 3155 million USD, and this downward trend continued in 2023 when revenue fell to about 2676 million USD. Although there was a modest rebound in 2024 to nearly 2820 million USD, the revenue figures have not returned to their 2021 peak. Gross profit and operating income mirrored these movements, with gross profit dipping from 2207 million USD in 2021 to around 1537 million USD in 2023 before a slight recovery in 2024, while operating income fell even more sharply—indicating significant compressions in the company’s profitability margins. Net income tracked a similar pattern. After reaching roughly 1015 million USD in 2021, net income dropped by nearly 30% to about 716 million USD in 2022 and further declined to around 449 million USD in 2023, with only a partial recovery to 542 million USD in 2024. These year-over-year swings—especially declines surpassing 20% from 2021 to subsequent years—suggest that TERADYNE is facing challenges that could stem from intensified market competition, operational adjustments, or broader industry headwinds in the technology and electronics testing sectors. Overall, while the company demonstrates operational resilience and some recovery in 2024, the sustained declines in profitability metrics signal caution regarding its medium-term financial health and sustainability.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.